TRIAMTERENE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triamterene and what is the scope of freedom to operate?
Triamterene
is the generic ingredient in two branded drugs marketed by Concordia, Agnitio, and Hibrow Hlthcare, and is included in three NDAs. Additional information is available in the individual branded drug profile pages.There are seventeen drug master file entries for triamterene. Four suppliers are listed for this compound.
Summary for TRIAMTERENE
US Patents: | 0 |
Tradenames: | 2 |
Applicants: | 3 |
NDAs: | 3 |
Drug Master File Entries: | 17 |
Finished Product Suppliers / Packagers: | 4 |
Raw Ingredient (Bulk) Api Vendors: | 130 |
Clinical Trials: | 8 |
Patent Applications: | 6,454 |
Drug Prices: | Drug price trends for TRIAMTERENE |
Drug Sales Revenues: | Drug sales revenues for TRIAMTERENE |
What excipients (inactive ingredients) are in TRIAMTERENE? | TRIAMTERENE excipients list |
DailyMed Link: | TRIAMTERENE at DailyMed |
Recent Clinical Trials for TRIAMTERENE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
University of California, Irvine | Phase 4 |
Vanderbilt University | Phase 4 |
West China Hospital | Phase 4 |
Pharmacology for TRIAMTERENE
Drug Class | Potassium-sparing Diuretic |
Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Medical Subject Heading (MeSH) Categories for TRIAMTERENE
Anatomical Therapeutic Chemical (ATC) Classes for TRIAMTERENE
US Patents and Regulatory Information for TRIAMTERENE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Concordia | DYRENIUM | triamterene | CAPSULE;ORAL | 013174-001 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hibrow Hlthcare | TRIAMTERENE | triamterene | CAPSULE;ORAL | 214768-001 | Jul 6, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Agnitio | TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581-002 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Agnitio | TRIAMTERENE | triamterene | CAPSULE;ORAL | 211581-001 | Aug 19, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Concordia | DYRENIUM | triamterene | CAPSULE;ORAL | 013174-002 | Approved Prior to Jan 1, 1982 | AB | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Hibrow Hlthcare | TRIAMTERENE | triamterene | CAPSULE;ORAL | 214768-002 | Jul 6, 2022 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.